ப்ரொஃபெஸர் சால்வடார் லூரியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃபெஸர் சால்வடார் லூரியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃபெஸர் சால்வடார் லூரியா Today - Breaking & Trending Today

Expert discusses the discoveries that enabled RNA vaccines for COVID-19

Expert discusses the discoveries that enabled RNA vaccines for COVID-19
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , Nancy Hopkins , David Housman , Claire Moore , Bob Weinberg , David Baltimore , Susan Berget , National Cancer Institute , National Institutes Of Health , Drug Administration , Cancer Center , Cold Spring Harbor Laboratory , National Science Foundation , Institute Professor Phillipa Sharp , Department Of Biology , Tufts Medical School , Cancer Research , Koch Institute For Integrative Cancer Research , Baylor College Of Medicine , American Cancer Society , Institute Professor Phillip , Koch Institute , Integrative Cancer Research , Professor Sharp , Professor Salvador Luria , National Institutes ,

3 Questions: Phillip Sharp on the discoveries that enabled RNA vaccines for Covid-19

Credits:
Photo courtesy of the School of Science
Previous image
Next image
Some of the most promising vaccines developed to combat Covid-19 rely on messenger RNA (mRNA) a template cells use to carry genetic instructions for producing proteins. The mRNA vaccines take advantage of this cellular process to make proteins that then trigger an immune response that targets SARS-CoV-2, the virus that causes Covid-19.
Compared to other types of vaccines, recently developed technologies allow mRNA vaccines to be rapidly created and deployed on a large-scale crucial aspects in the fight against Covid-19. Within the year since the identification and sequencing of the SARS-CoV-2 virus, companies such as Pfizer and Moderna have developed mRNA vaccines and run large-scale trials in the race to have a vaccine approved by the U.S. Food and Drug Administration a feat unheard of with traditional vaccines using live attenuated or inactive vi ....

United States , Nancy Hopkins , David Housman , Claire Moore , Bob Weinberg , David Baltimore , Susan Berget , National Cancer Institute , National Institutes Of Health , Drug Administration , Cancer Center , Cold Spring Harbor Laboratory , National Science Foundation , Institute Professor Phillipa Sharp , Department Of Biology , Tufts Medical School , Cancer Research , Koch Institute For Integrative Cancer Research , Baylor College Of Medicine , American Cancer Society , Institute Professor Phillip , Koch Institute , Integrative Cancer Research , Professor Sharp , Professor Salvador Luria , National Institutes ,